FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

725734005: Bosentan monohydrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3444685011 Bosentan monohydrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3444686012 Bosentan monohydrate en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bosentan monohydrate Is a Bosentan false Inferred relationship Existential restriction modifier
Bosentan monohydrate Has disposition Endothelin receptor antagonist true Inferred relationship Existential restriction modifier
Bosentan monohydrate Is modification of Bosentan true Inferred relationship Existential restriction modifier
Bosentan monohydrate Is a Substance with endothelin receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Bosentan 62.5mg tablets (Cipla EU Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) 56 tablet Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Cipla EU Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Cipla EU Ltd) 56 tablet Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets Has specific active ingredient False Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets Has specific active ingredient False Bosentan monohydrate Inferred relationship Existential restriction modifier
Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet Has specific active ingredient False Bosentan monohydrate Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets 56 tablet Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Tracleer 62.5mg tablets (Janssen-Cilag Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Product containing precisely bosentan 125 milligram/1 each conventional release oral tablet Has specific active ingredient False Bosentan monohydrate Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets 56 tablet Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Viatris UK Healthcare Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Viatris UK Healthcare Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Zentiva Pharma UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Zentiva Pharma UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Stayveer 62.5mg tablets (AMCo) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Stayveer 125mg tablets (AMCo) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Stayveer 62.5mg tablets (AMCo) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Stayveer 125mg tablets (AMCo) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Milpharm Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Milpharm Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Milpharm Ltd) 56 tablet Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Milpharm Ltd) 56 tablet Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Accord Healthcare Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Accord Healthcare Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Accord Healthcare Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Accord Healthcare Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Dr Reddy's Laboratories (UK) Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Dr Reddy's Laboratories (UK) Ltd) Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Dr Reddy's Laboratories (UK) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Dr Reddy's Laboratories (UK) Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Bosentan monohydrate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start